Concepedia

Advanced Age Is an Independent Risk Factor for Severe Infections and Mortality in Patients Given Anti–Tumor Necrosis Factor Therapy for Inflammatory Bowel Disease

Mario Cottone, Anna Kohn, Marco Daperno, Alessandro Armuzzi, Luisa Guidi, R. D’Incà, Fabrizio Bossa, Erika Angelucci, Livia Biancone, Paolo Gionchetti,

Clinical Gastroenterology and Hepatology · 2010 · 360 citations · 20 references

DOI

Concepts

References

20

Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis

Paul Rutgeerts, William J. Sandborn, Brian G. Feagan et al. · New England Journal of Medicine · 2005 · 3.9K citations · Full text

, , +14

Infliximab for the Treatment of Fistulas in Patients with Crohn's Disease

Daniel H. Present, Paul Rutgeerts, Stephan Targan et al. · New England Journal of Medicine · 1999 · 2.7K citations · Full text

, , +14

Classification of Inflammatory Bowel Disease

J E Lennard‐Jones · Scandinavian Journal of Gastroenterology · 1989 · 2K citations

, , +17

Human Anti–Tumor Necrosis Factor Monoclonal Antibody (Adalimumab) in Crohn’s Disease: the CLASSIC-I Trial

Stephen B. Hanauer, William J. Sandborn, Paul Rutgeerts et al. · Gastroenterology · 2006 · 1.7K citations

, , +13

The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management

Gert Van Assche, James O. Lindsay, Marc Lémann et al. · Journal of Crohn s and Colitis · 2010 · 1.5K citations

, , +11